Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresis.

Franziska OlmLena PanseJosefina H DykesDaniel BexellThomas LaurellStefan Scheding

Published in: Stem cell research & therapy (2021)

These results demonstrate the potential use of label-free acoustophoresis for PBPC processing and its potential to develop label-free, non-contact tumor cell enrichment and purging procedures for future clinical use.

Keyphrases

label free
bone marrow
cell therapy
stem cells
current status
risk assessment
human health
climate change